Growth hormone status in morbidly obese subjects and correlation with body composition
Authors:
- 1 June 2006
- journal article
- research article
- Published by Springer Nature in Journal of Endocrinological Investigation
- Vol. 29 (6) , 536-543
Abstract
Morbidly obese subjects are characterized by multiple endocrine abnormalities and these are paralleled by unfavorable changes in body composition. In obese individuals, either 24-h spontaneous or stimulated GH secretion is impaired without an organic pituitary disease and the severity of the secretory defect is proportional to the degree of obesity. The GHRH+arginine (GHRH+ARG) test is likely to be the overall test of choice in clinical practice to differentiate GH deficiency (GHD) patients. Similarly to other provocative tests, GHRH+ARG is influenced by obesity per se. Therefore, a new cut-off limit of peak GH response of 4.2 µg/l in obese subjects has been recently assumed. The aim of the present study was to investigate the reciprocal influence between decreased GH secretion and body composition in a group of 110 morbidly obese subjects, using the new cut-off limit of peak GH response to GHRH+ARG test for these subjects. In our study, GHD was identified in 27.3% of the obese subjects, without gender difference. In GDH obese subjects body mass index (BMI), waist circumference, waist-to-hip ratio (WHR), fat mass (FM), and resistance (R) were higher while reactance (Xc), phase angle, body cell mass (BCM), IGF-I, or IGF-I z-scores were lower than in normal responders (p<0.001). In all obese subjects, GH peak levels showed a negative correlation with age, BMI, waist circumference and FM, and a positive correlation with IGF-I. In the stepwise multiple linear regression, waist circumference and FM were the major determinants of GH peak levels and IGF-I. In conclusion, using the new cut-off limit of peak GH response to GHRH+ARG test for obese subjects, about 1/3 morbidly obese subjects were GHD. GHD subjects showed a significantly different body composition compared with normal responders, and the secretory defect was correlated to different anthropometric variables with waist circumference and FM as the major determinants.Keywords
This publication has 35 references indexed in Scilit:
- Lean Body Mass Is a Major Determinant of Levothyroxine Dosage in the Treatment of Thyroid DiseasesThe Journal of Clinical Endocrinology & Metabolism, 2005
- The Severity of Growth Hormone Deficiency Correlates with the Severity of Cardiac Impairment in 100 Adult Patients with Hypopituitarism: An Observational, Case-Control StudyThe Journal of Clinical Endocrinology & Metabolism, 2004
- Adiposity and Fat Distribution Outcome Measures: Assessment and Clinical ImplicationsObesity Research, 2002
- Relationships between IGF-I and age, gender, body mass, fat distribution, metabolic and hormonal variables in obese patientsInternational Journal of Obesity, 1999
- The Growth Hormone (GH) Response to the Arginine Plus GH-Releasing Hormone Test Is Correlated to the Severity of Lipid Profile Abnormalities in Adult Patients with GH DeficiencyThe Journal of Clinical Endocrinology & Metabolism, 1999
- Growth hormone in obesityInternational Journal of Obesity, 1999
- Comparison between Insulin-Induced Hypoglycemia and Growth Hormone (GH)-Releasing Hormone + Arginine as Provocative Tests for the Diagnosis of GH Deficiency in Adults1The Journal of Clinical Endocrinology & Metabolism, 1998
- Discriminating between body fat and fluid changes in the obese adult using bioimpedance vector analysisInternational Journal of Obesity, 1998
- A new method for monitoring body fluid variation by bioimpedance analysis: The RXc graphKidney International, 1994
- Interaction of free fatty acids and arginine on growth hormone secretion in manMetabolism, 1994